GERN Geneva presentation will be during the day, Nov 17th
MENLO PARK, Calif. -- (Business Wire) -- Nov. 15, 2004
Geron Corporation (Nasdaq:GERN) will be presenting an
update of the company's product development programs at SG Cowen's 5th
Annual Global Health Care Conference in Geneva, Switzerland on
Wednesday, November 17, 2004, at 3:30 p.m. Central European Time.
Thomas B. Okarma, Ph.D., M.D., Geron's president and chief executive
officer, will be giving the presentation.
¶ The presentation will cover Geron's portfolio of telomerase-based
anti-cancer therapies, including GRN163L and the telomerase vaccine,
as well as progress in its human embryonic stem cell (hESC) programs
for the treatment of spinal cord injury, diabetes and heart disease.
¶ The audio and slide presentation will be available at the
following web address:
talkpoint.com. The webcast
will be archived for 30 days.
¶ For further information, please contact Geron Corporation at
650-473-7765 or visit Geron's website at www.geron.com.
¶ Geron is a biopharmaceutical company focused on developing and
commercializing therapeutic and diagnostic products for cancer based
on its telomerase technology, and cell-based therapeutics using its
human embryonic stem cell technology.
Contacts:
Geron Corporation
David L. Greenwood, 650-473-7765 |
